Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2

Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2

BackgroundAlthough tremendous success has been achieved in the development and deployment of effective COVID-19 vaccines, developing effective therapeutics for the treatment of those who do come down with the disease has been with limited success. To repurpose existing drugs for COVID-19, we previou...

Full description

Bibliographic Details
Main Authors: Shaibu Oricha Bello, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, Aishatu Yahaya Bello, Yusuf Yahaya Deeni, Ifeoma Okoye
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
erythromycin
retapamulin
pyridoxine
folic acid
ivermectin
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1273982/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1273982/full

Similar Items